<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02338505</url>
  </required_header>
  <id_info>
    <org_study_id>21264/14</org_study_id>
    <nct_id>NCT02338505</nct_id>
  </id_info>
  <brief_title>Teleassisted Surgery for Gynecological Disease in Obese Patients - OB-ALFX</brief_title>
  <acronym>OB-ALFX</acronym>
  <sponsors>
    <lead_sponsor>
      <agency>Catholic University of the Sacred Heart</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>SOFAR S.p.A.</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>Catholic University of the Sacred Heart</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Phase II prospective single-institutional study.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The aim of this Phase II prospective single-institutional study is to assess feasibility and
      early complications rate of Telelap ALF-X surgical treatment in obese patients affected by
      gynecological disease.
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Not yet recruiting</last_known_status>
  <start_date>February 2015</start_date>
  <completion_date type="Anticipated">February 2016</completion_date>
  <primary_completion_date type="Anticipated">February 2016</primary_completion_date>
  <phase>Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>intraoperative complication rate</measure>
    <time_frame>intraoperative</time_frame>
    <description>Operative time, conversion rate, estimated blood loss, visceral injury</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>postoperative complication rate</measure>
    <time_frame>30 days</time_frame>
    <description>Ileus, bleeding, infection/sepsi, thrombosis, rehospitalization, death</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">50</enrollment>
  <condition>Benign, Premalignant and Malignant Gynecological Disease Confined to the Pelvis</condition>
  <arm_group>
    <arm_group_label>Telelap ALF-X in obese patients with gynecological disease</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Telelap ALF-X</intervention_name>
    <description>Patients placed in the dorsal lithotomic position with both legs supported in Allen stirrups with a Trendelenburg tilt. After achieving pneumoperitoneum (12mmHg) through a trans umbilical open access technique, intra-abdominal visualization was obtained with a 10mm 0° HD 3D telescope. During the trocar placement the operative room nurses supported the surgeon in the docking procedures approaching the robotic arms to the operative table, in places established for pelvic surgery. The cockpit is located in one corner of our square shape room; the operative table is surrounded by the three robotic arms unit.
Through the teleassisted operative ports we could make use of several type of instruments. Movements of both instruments and optic were completely carried out by the surgeon from the cockpit according to the needs of the procedure.</description>
    <arm_group_label>Telelap ALF-X in obese patients with gynecological disease</arm_group_label>
    <other_name>ALF-X teleassisted surgery</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  informed consent

          -  30 ≤ BMI &lt; 40

          -  ASA &lt; III

          -  Ovarian Cyst

          -  Prophylactic bilateral salpingo-oophorectomy

          -  Ectopic Pregnancy

          -  Pelvic Inflammatory Disease

          -  Sterility/Infertility

          -  Benign uterine disease (fibromatosis, adenomyosis)

          -  Endometrial hiperplasia

          -  Early-stage Endometrial Cancer

          -  Preneoplastic lesions of the cervix

          -  IA1 Cervical Cancer

          -  Pelvic endometriosis

        Exclusion Criteria:

          -  Pregnancy

          -  Liver disease

          -  Coagulopathies

          -  Clinical conditions contraindicating laparoscopy
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>90 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Salvatore Gueli Alletti, MD</last_name>
    <email>gueliallettis@gmail.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Salvatore Gueli Alletti, MD</last_name>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Catholic University of Sacred Heart Rome,</name>
      <address>
        <city>Rome,</city>
        <state>Rome</state>
        <zip>00168</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Giovanni Scambia, Professor</last_name>
      <phone>+39-06-30156279</phone>
      <email>giovanni.scambia@rm.unicatt.it</email>
    </contact>
    <investigator>
      <last_name>Giovanni Scambia, Professor</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Cristiano Rossitto, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Salvatore Gueli Alletti, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Anna Fagotti, PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Francesco Fanfani, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Italy</country>
  </location_countries>
  <results_reference>
    <citation>Gidaro S, Buscarini M, Ruiz E, Stark M, Labruzzo A. Telelap Alf-X: a novel telesurgical system for the 21st century. Surg Technol Int. 2012 Dec;22:20-5.</citation>
    <PMID>23225591</PMID>
  </results_reference>
  <results_reference>
    <citation>Gidaro S, Altobelli E, Falavolti C, Bove AM, Ruiz EM, Stark M, Ravasio G, Lazzaretti SS, Maurizio B. Vesicourethral anastomosis using a novel telesurgical system with haptic sensation, the Telelap Alf-X: a pilot study. Surg Technol Int. 2014 Mar;24:35-40.</citation>
    <PMID>24706079</PMID>
  </results_reference>
  <results_reference>
    <citation>Lococo A, Larocca V, Marino F, De Filippis AF, Cesario A, Lococo F. Experimental Robotic Pulmonary Lobectomy With the TELELAP/ALFX System in the Ovine Model. Surg Innov. 2015 Jun;22(3):252-6. doi: 10.1177/1553350614549633. Epub 2014 Sep 15.</citation>
    <PMID>25225214</PMID>
  </results_reference>
  <results_reference>
    <citation>Falavolti C, Gidaro S, Ruiz E, Altobelli E, Stark M, Ravasio G, Ravasio G, Lazzaretti SS, Buscarini M. Experimental Nephrectomies Using a Novel Telesurgical System: (The Telelap ALF-X)-A Pilot Study. Surg Technol Int. 2014 Nov;25:37-41.</citation>
    <PMID>25433265</PMID>
  </results_reference>
  <verification_date>January 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>January 12, 2015</study_first_submitted>
  <study_first_submitted_qc>January 13, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">January 14, 2015</study_first_posted>
  <last_update_submitted>January 13, 2015</last_update_submitted>
  <last_update_submitted_qc>January 13, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">January 14, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Catholic University of the Sacred Heart</investigator_affiliation>
    <investigator_full_name>Prof. Giovanni Scambia</investigator_full_name>
    <investigator_title>Professor</investigator_title>
  </responsible_party>
  <keyword>Robotic Surgery</keyword>
  <keyword>Telelap-ALFX</keyword>
  <keyword>Gynecological disease</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Precancerous Conditions</mesh_term>
    <mesh_term>Genital Diseases, Female</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

